Chemoinformaics analysis of Lucidinprimeveroside
Molecular Weight | 564.496 | nRot | 6 |
Heavy Atom Molecular Weight | 536.272 | nRig | 29 |
Exact Molecular Weight | 564.148 | nRing | 5 |
Solubility: LogS | -2.905 | nHRing | 2 |
Solubility: LogP | 0.409 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 2 |
nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 14 | No. of Arom Bond | 12 |
nHA | 14 | APOL | 73.3182 |
nHD | 8 | BPOL | 36.7698 |
QED | 0.095 |
Synth | 4.824 |
Natural Product Likeliness | 1.724 |
NR-PPAR-gamma | 0.554 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.006 |
Pgp-sub | 0.933 |
HIA | 0.973 |
CACO-2 | -6.558 |
MDCK | 0.00000723 |
BBB | 0.091 |
PPB | 0.903696 |
VDSS | 0.466 |
FU | 0.114806 |
CYP1A2-inh | 0.041 |
CYP1A2-sub | 0.037 |
CYP2c19-inh | 0.016 |
CYP2c19-sub | 0.063 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.058 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.119 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.002 |
CL | 1.036 |
T12 | 0.616 |
hERG | 0.136 |
Ames | 0.816 |
ROA | 0.006 |
SkinSen | 0.954 |
Carcinogencity | 0.176 |
EI | 0.457 |
Respiratory | 0.054 |
NR-Aromatase | 0.721 |
Antiviral | Yes |
Prediction | 0.862411 |